Michael serves as a primary research and analytical resource for Innovations and its partners with a focus on market assessment of new medical technologies. Prior to joining the Clinic, he spent more than 11 years at Health Research International, an independent medical market research and consulting firm, most recently as Vice President. This experience entailed working closely with a broad range of medical technology firms from local start-ups to multinationals. Michael earned a BA in business administration (cum laude, Marketing major) from the Richard T. Farmer School of Business at Miami University.
Susan Bernat is responsible for the strategic planning, development and implementation of Communications, Marketing and Technology Systems Infrastructure & Integration for Cleveland Clinic Innovations. Susan is also responsible for the development and implementation of the annual Medical Innovation Summit. Prior to assuming this role in January 2014, Susan was the Director, Operations & Finance for CCI since November 2004. She was responsible for all fiduciary management including fiscal planning and other related financial activities. Susan also assists with establishing and implementing strategic goals and oversees long-range facilities planning. She served as the Director of Finance for the GCIC with responsibilities including development and implementation of strategy for ensuring financing of the GCIC consortium operations and management of financial performance and budgets. Prior to joining CCI, she was responsible for budget and contract negotiations within cardiology research at Cleveland Clinic. She received her undergraduate degree in Accounting from Kent State University, and an MBA from Cleveland State University.
Marwane Berrada has over 13 years of experience in medical device product development and commercialization. Prior to joining CCI, Marwane was Managing Director at Bavaria Medical Technology, a product development company. In addition, Marwane has held various engineering, managerial, and executive management positions in companies such Microvena, ev3, CryoCath Technologies, Vascular NanoTransfer and OligoMedic. Product expertise has been in percutaneous therapies such as electrophysiology, structural heart, cardiovascular and endovascular devices, in addition to product commercialization of orthopedic implants. Through his engineering and business backgrounds, Marwane is experienced in leading both traditional and virtual R&D teams throughout the entire development life-cycle including US and European regulatory tracks. He’s also listed in 8 patents.
Marwane received his BS and MS in Mechanical Engineering from the University of Minnesota and an MBA in Finance from McGill University.
Dae Capobianco has over 8 years of experience in medical device sales and marketing. Prior to joining CCI, Dae was a Senior Clinical Specialist at Medtronic Inc. Her work centered on providing healthcare professionals and patients clinical, technical, and educational training and support on life-saving medical technologies within the Cardiac Rhythm Disease Management Division as well as managing and developing customer relationships in accounts such as Cleveland Clinic. Additionally, she led continuing education for nurses as a program manager and speaker, cross-trained to perform research in company sponsored clinical trials, and was a proactive committee member in the development and design of corporate customer education and training.
Dae received her BSE in Biomedical Engineering with a concentration in polymeric materials and her MBA with a focus in healthcare, project management, and entrepreneurship from Case Western Reserve University.
Veronika’s function serves as liaison and administrative, technical, and operational resource for the Global Cardiovascular Innovation Center team. She has an extensive background providing support to senior-level Executives and world class service to all valued customers.
Kelly B. Emerton, PhD, joins the GCIC team as Sr. Director of Product Development, lending her medical device industry experience towards the GCIC mission of developing and commercializing cardiovascular technology. Prior to joining the GCIC team , she spent 6+ years across Medtronic business units (Spine and Endovascular Therapy divisions) leading multiple major development programs with cross-functional execution. Her background includes US and outside US regulatory approvals for Class III implantable and combination-product devices for orthopedic and endovascular therapy indications. During her Endovascular Therapy tenure, she was responsible for leading multiple pipeline programs within the thoracic aortic product portfolio.
Kelly received a BSE degree in Biomedical Engineering from Michigan Technological University, and an MS and PhD in Biomedical Engineering from City College at the City University of New York.
Maria joined CCI in 2014 as a member of the Commercial Transactions team. Prior to joining CCI, Maria was at NewYork-Presbyterian (NYP), the university hospital of Columbia and Cornell, where she developed and implemented business restructuring and cost containment programs. While at NYP, she was appointed to the Board of Directors of the Emerging Leadership Council. Maria also previously worked at Strategic Capital, where she focused on commercial real estate and special situation investment opportunities. In total, Maria has structured more than $700M in investments in Latin America, Western Europe and the United States. Throughout her career, she has been involved with various early stage companies in the HIT space.
Maria holds a BS in Economics and Finance from Stony Brook University and a MA in Law and Diplomacy from The Fletcher School at Tufts University. She was a visiting student at GSAS, Harvard University. Maria is fluent in Spanish and speaks French and Mandarin Chinese.
As a member of the Commercialization team, Kaleigh is the initial point of contact for Cleveland Clinic inventors who are considering the commercial potential of their inventions. In her current role, she advises inventors on the commercialization process and connects them with available resources. She works collaboratively with the Innovations team in the identification, marketing and commercialization of healthcare technologies. Kaleigh joins CCI with management experience in medical device sales. She received her BBA in Marketing, with a minor in Entrepreneurship, from the Richard T. Farmer School of Business at Miami University.
A native of Eastern Ohio, Dr. Thomas J. Graham attended Shady Side Academy in Pittsburgh before earning his college degree in Chemistry (BA with Honors) from Williams College in Massachusetts. He received his Doctor of Medicine (MD) degree from The University of Cincinnati College of Medicine, and then served his residency in Orthopaedic Surgery at The University of Michigan in Ann Arbor. Dr. Graham completed his fellowship in Hand and Upper Extremity Surgery at the renowned Indiana Hand Center. He extended his training as a Visiting Surgeon at the Mayo Clinic, studying surgery of the elbow.
Dr. Graham is Board Certified in Orthopaedic Surgery, and holds a Certificate of Added Qualifications in Surgery of the Hand. In addition, he completed the Executive Management Program in Health Care Administration jointly sponsored by the Cleveland Clinic Foundation the Weatherhead School of Western Reserve University.
In 1994, he joined the Department of Orthopaedic Surgery at The Cleveland Clinic and became the Head of their Upper Extremity Division before his departure in 2000. While at the Clinic, Graham was recognized for his clinical expertise in surgery of the hand, wrist and elbow with special concentration on complicated reconstruction after trauma, complex elbow disorders and congenital hand surgery; he also developed a special focus on the care of the elite athlete's hand and elbow disorders. Dr. Graham served as the Hand Surgery Consultant for all of the professional sports teams in Cleveland, as well as the Cleveland Symphony and the Rock and Roll Hall of Fame. From 1991-1994 he was affiliated with the United States Olympic Committee as an Exercise Physiologist during the 1994 Los Angeles Olympic Quadrennium.
In 2000, Graham accepted the position as Director of The Curtis National Hand Center and Chief, UMH Division of Hand Surgery in Baltimore, Maryland. With the singular Congressional Designation, this Hand Center is the world's largest and serves as a focal training center in the specialty. He also serves as the Vice-Chairman of the Department of Orthopaedic Surgery at Union Memorial Hospital and has appointments as an Associate Professor in both Orthopaedic and Plastic Surgery at Johns Hopkins.
Dr. Graham has published numerous articles on almost every aspect of hand and upper extremity surgery, lectured widely around the world and edited several books. He founded and directed The Cleveland Clinic's Orthopaedic International Educational Symposium at the Greenbrier Resort. Dr. Graham had an extended administrative role as Chief of the Orthopaedic Specialty Hospital of Cleveland from 1997-2000.
He is among the youngest doctors ever to be chosen for the prestigious publication, Woodward & White's Best Doctors in America as well as Castle Connolly's America's Top Doctors. Graham was repeatedly voted as one of "Cleveland's Top Doctors" in Cleveland Magazine, and then received the same honor from his peers in Baltimore by inclusion in "Top Doctors" in Baltimore Magazine. He was chosen for Strathmore's Who's Who in 2000. Dr. Graham has been the subject of several magazine articles in the popular press and has been the recipient of many awards for his clinical and academic contributions including the Bausch & Lomb Honorary Science Medal, The Riordan-Brand Award in Hand Biomechanics, and the prestigious John J. Fahey, Jr., M.D., North American Traveling Fellowship. Graham was again among the youngest surgeons to be admitted for fellowship in the American Orthopaedic Association, the highest academic honor bestowed in the specialty.
Graham was featured on ABC's Nightline for his role in the treatment of 9/11 survivors. His involvement with these heroes was also chronicled in an exhibit at the Smithsonian Institution. He has also been featured on the Golf Channel, ESPN, The Daily Show and other media outlets.
Presently, Dr. Graham's practice is recognized as the premier destination for the care of the professional athletes and entertainer's hand and wrist. His skills are requested by athletes from all major sports and he maintains formal relationships with the many franchises, agencies and leagues as a Team Physician or their official Hand Surgery Consultant, including the Baltimore Ravens (NFL), Philadelphia Flyers (NHL), Cleveland Indians (MLB), Washington Nationals (MLB) and Toronto Blue Jays (MLB), Cleveland Cavaliers (NBA) and Cleveland Browns (NFL). He is the recognized Hand Surgery Consultant for the NHL, MLB and NFL and his work with the PGA Tour is well-chronicled.
Because of Dr. Graham's extensive experience and relationships in professional sports, he began an exciting new endeavor in 2002 as the Director of MedStar SportsHealth; the Sports Operations Division of the mid-Atlantic's largest healthcare system. Through this involvement, he was able to architect a large scale program for the care of the athlete and active individual through partnerships between his Health System and teams, corporations, schools and the Government. In 2008, Dr. Graham paid the ultimate honor to his longtime patient and friend, Mr. Arnold Palmer, by launching the Arnold Palmer SportsHealth Center in Baltimore, destined to be among the country's premier centers for the care of sports injuries. In addition to his status as the Founder, Dr. Graham serves as the Surgeon-in-Chief of the Palmer Center, directing its operations and strategy.
Graham's many developments in surgical science, including his many patents on implants and other devices have provided his specialty with the most contemporary tools for advancing the health and function of patients worldwide. He has started and divested medical device companies, is a principal in operating corporations and serves on the Boards of several concerns in the medical device space.
In 2010, Dr. Graham's career was marked by a return to the Cleveland Clinic in a role that leveraged both his extensive accomplishments in medical leadership and entrepreneurial endeavor, as well as his unique practice focus. He was named Chairman of Cleveland Clinic Innovations and Vice-Chairman of the Department of Orthopaedic Surgery. Dr. Graham was excited and inspired to join these two already-successful facets of the Clinic's diverse base, and quickly began to grow the identity and scope of the clinical and commercial concerns. Graham believes that the Cleveland Clinic will add to its considerable legacy as a local medical icon and international healthcare resource by pursuing clinical excellence while fostering and nurturing creative thought and transcendent ideas.
Dr. Graham is married to his childhood sweetheart, CeCe, and they have two daughters, Margaret and Elizabeth. He enjoys golf, outdoor activities, travel and anatomic drawing. Contact Information:
Mark Low comes to GCIC with a career of building successful programs to introduce new concepts and new modalities to new markets. He has managed all facets of product and market development spanning diagnostic and interventional cardiology, interventional radiology and neuroradiology, stroke treatment, image-guided surgery, drug delivery and oncology. He has served on the senior management team of TomTec Imaging Systems, Image Guided Technologies, EKOS Corporation, and Sonus Pharmaceuticals.
Prior to concentrating his focus on start-up ventures and early stage market development, Mr. Low held progressively more responsible and trailblazing positions in marketing and business development for Hewlett-Packard's Medical Products Group. Specializing in cardiovascular ultrasound, Mr. Low managed high performance cardiac diagnostic systems, introduced products to new market segments including private office and interventional cardiology, and developed new applications including 3D and stress echocardiography, and catheter-based intravascular ultrasound. In conjunction with these programs Mr. Low managed strategic relationships with various corporate partners, investors, universities, inventors, clinical investigators and manufacturers. Mr. Low received a B.A. degree in Natural Science from Johns Hopkins University, an M.S. degree in Physiology from the Medical College of Wisconsin, and an M.S. degree in Technical Communication from Rensselaer Polytechnic Institute.
Matt McBride has been with the Innovations group since 2012, focusing on the assessment, commercialization, and business development behind medical break-throughs at the Cleveland Clinic. Prior to joining CCI, Matt served as a Naval Officer at several commands throughout the world. As a Naval Officer he served as Executive Officer of the Military Sealift Command in Diego Garcia, Program Manager for the V-22 Osprey in Philadelphia, and as the Contract Administrator for Forward Operating Base, Camp Leatherneck, in Afghanistan.
Matt received a BS in political science with a focus on engineering, math and science in 2006, from the United States Naval Academy. Matt is currently pursuing his Executive MBA at Case Western Reserve University (2015).
Sonja O'Malley has over 20 years of experience in healthcare information technology. Prior to joining CCI, Sonja was responsible for managing the global life sciences client portfolio at Axentis. Axentis, a Wolters Kluwer business, is a software provider of on-demand solutions used by life science customers and other highly regulated industries to minimize their exposure to risk and optimize business performance; a $5 billion (2010) company with 19,000 employees worldwide. Sonja's work has spanned clinical laboratory medicine as a MT (ASCP), consulting in the health care practice of Andersen Consulting, directing the process improvement practice within a health insurance organization, and building multiple startups as an early employee.
Sonja is a certified PMP from the Project Management Institute and has a BS in medical technology from Miami University and an MBA from the Weatherhead School of Management at Case Western Reserve University.
Jason Ospina has over 10 years of experience in Life Sciences and over 2 years of experience in technology commercialization. Prior to joining CCI, Jason was a post-doctoral fellow at Cleveland Clinic's Lerner Research Institute. His research centered on the delineation of mechanisms regulating Hedgehog signal transduction and the influence of protein phosphorylation on pathway outcomes.
Jason received his PhD in genetics from Case Western Reserve University, where his thesis work examined nuclear protein dynamics and transport, as well as ribonucleoprotein biogenesis.
Marcie has over 10 years of experience in medical device product development and commercialization. Prior to joining CCI, Marcie held several product development positions at Kensey Nash Corporation in the fields of interventional cardiology and soft tissue repair, concluding as a Senior Biomaterials Engineer.
Marcie received her BS and MS in materials engineering from Drexel University.
Joe has almost a decade of technology commercialization experience, previously serving as a senior member of Cleveland Clinic’s New Venture group, and vice president and general counsel for The University of Akron Research Foundation, where he was instrumental in numerous corporate ventures and international deals.
Joe received his BS in biology from John Carroll University and his JD and MBA in finance from The University of Akron, where the Ohio governor appointed him to serve on the university's Board of Trustees.
Dhanesh Shah has over 6 years of experience in healthcare corporate finance, strategy and business development. Prior to joining CCI, Dhanesh worked in Division of Finance at Cleveland Clinic, overseeing Clinic’s debt capital portfolio. A strong background in economics and accounting, his past experience has been with financial services organizations focused on structured products ratings and financial auditing.
Dhanesh has received a BA in economics/accounting and his MS in accounting/taxation from University of Mumbai. He received an MBA from Case Western Reserve University.
Sarah has over 20 years in healthcare and is recognized for her expertise in practice management and strategic and business planning. Prior to rejoining CCF, Sarah worked as a Consultant at The Gateway Group, Vice President of Medical Operations at The MetroHealth System, and as an Administrator at CCF. Her work centered on directing and managing medical group practices, developing and executing strategic initiatives, front end revenue enhancement and improving the performance of existing product lines.
Sarah received her BS in business administration degree from John Carroll University and her MBA from Cleveland State University.
Charles Steiner has over 25 years of experience in medical technology development. Prior to joining CCI, Charles was a product development engineer for the Center for Neurological Restoration and a business and technology developer for the Center for Minimally Invasive Surgery at Cleveland Clinic. His contributions have been in the field of surgical navigation for cranial and spinal indications, neuromodulation for movement and cognitive indications as well as neuromodulation for headache and autonomic indications.
Charles received his BS in chemistry and computer science from Case Western Reserve University.
Prior to joining the GCIC, Tom served as Executive Director of the Chamber of Commerce in Beachwood where he coordinated economic development efforts for the city. During his tenure, he helped more than 20 international companies establish their North America headquarters in Beachwood. Tom is committed to the Northeast Ohio community, having served as chair of the Northern Ohio Area Chambers of Commerce (NOACC). He is also a frequent guest columnist in publications such as Crain’s Cleveland Business, Inside Business and the Cleveland Jewish News. For his outstanding work, he has been recognized with awards from many economic development and community organizations. Tom was the Principal of TNS & Associates and prior to that served as a senior staff for academic institutions and social service organizations.
Tom received his BA from Kent State University and his MSW from the Wurzweiler School of Social Work.
Nisha Vagadia has over 14 years of experience in M&A and Biotechnology. Prior to joining CCI, Nisha was a Assoc. Director, Financial, Planning & Analysis (FP&A) at Acusphere. Previously she worked at Alkermes plc, PhaseForward and Arthur Andersen.
Nisha received her BS in business administration with a concentration in finance from University of Massachusetts at Amherst.
Neil is a Director with Cleveland Clinic Innovations. Neil primarily focuses on innovation management within both the Cleveland Clinic and its Healthcare Innovation Alliance Program. Neil has over 20 years of experience in biotechnology and technology commercialization. Prior to joining CCI, Neil Veloso was Senior Licensing Manager at the Case Western Reserve University Technology Transfer Office. There he sourced, negotiated and executed deals with pharmaceutical, medical device and diagnostic companies. Additionally, he was involved in medical imaging and pharmaceutical startup companies. At Athersys, his research and development work centered on process development of therapeutic proteins and small molecule drug screening.
Neil received a BA from the John Hopkins University, and MBA & MS from Case Western University.
216-621-2234 ext. 110
Michael has over 10 years of experience in medical device marketing. Prior to joining CCI, Michael was a Senior Product Manager at Integra Lifesciences. His work centered on commercializing spine and neurosurgical related technologies. Michael received his BS in electrical engineering from Villanova University and his MBA from Case Western Reserve University.
Jim is a Director in Cleveland Clinic Innovations. Jim primarily focuses on working with outside entities on Business Engineering services. These services include identifying outside people/organizations in their early stages and working with them to address their organization’s needs as they progress through their incubation on their early commercial operations period. Service offerings include business diagnostics, market segmentation, introduction to the healthcare financial ecosystem, key opinion leader and subject matter expertise introduction and other services needed by early stage organizations. Jim has over 20 years of experience in healthcare operations and consulting services. Prior to joining CCI, Jim was the Institute Administrator for the Cleveland Clinic’s Orthopaedic and Rheumatologic Institute and Director of the Cleveland Clinic Innovation’s Enterprise Solutions team. His work centered on monetizing workflows, trade secrets and non-IP protectable solutions. Jim has also worked at finding solutions and introducing partners centered around healthcare solutions.
Jim received his BSBA in Finance from John Carroll University. He has an MBA from Cleveland State University and has his Series 6 and 63 securities license.
Matt has over 7 years of writing and marketing experience. As a Business Associate of the Technology & Communications group, Matt develops content for all internal and external marketing and communications, supports all branding efforts, and helps to plan, promote and produce the Cleveland Clinic's Medical Innovation Summit. Prior to joining CCI, Matt was a Grant Writer for LNE Group, where he consulted on funding opportunities for clients in healthcare, renewable energy, and manufacturing industries.
Matt received his BA in English from the University of Notre Dame.
Innovations has facilitated several Cleveland Clinic Spin-Offs over the last decade. Click here to see our current portfolio.
The Alliance network strives to realize new opportunities for innovation by gaining a 360-degree perspective on healthcare and its future.
Cleveland Clinic © 2014